Biotech - Spark Newswire

2 minute read

What Is Going On With Clover Health Stock?

Today, 11:27 AM

Clover Health Investments Corp (NASDAQ: CLOV) spiked more than 13% on Wednesday in the regular session. What Happened: Clover Health stock shot up on a day when the so-called Stonks, or stocks favored by the retail investor crowd on social media, took the limelight.

AMC

2 minute read

Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know

By Chris Katje

Today, 11:27 AM

One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs. What Happened: Chamath Palihapitiya is launching four new SPACs targeting the biotechnology sector. Each SPAC is seeking to raise $200 million and will not contain warrants.

CLOV

1 minute read

Alpine Immune Sciences Says Presents ALPN-303 Data During 2021 EULAR Virtual Meeting

By Benzinga Newsdesk

Today, 11:27 AM

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today made an oral presentation of

ALPN

1 minute read

Catalent Shares Volatile Over Last Few Mins Amid Report US Gov’t. Discussing Producing AstraZeneca’s COVID-19 Vaccine In A Co. Factory

By Benzinga Newsdesk

Today, 11:27 AM

https://www.nytimes.com/2021/06/02/us/politics/astrazeneca-covid-vaccine.html

AZN

2 minute read

Sorrento Therapeutics Looks Like It May Have Broken Out Of A Falling Wedge Pattern

By Tyler Bundy

Today, 11:27 AM

Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares are trading higher Wednesday after the company announced it completed an acquisition of ACEA Therapeutics. The merger was completed June 1, and ACEA became a wholly owned subsidiary of Sorrento.

SRNE

2 minute read

Myocarditis Cases Probably Linked to Pfizer COVID-19 Vaccine, Says Israel Health Ministry: Reuters

By Vandana Singh

Today, 11:27 AM

Israel’s Health Ministry has reportedly found the small number of heart inflammation cases, observed mainly in young men who…

BNTX

2 minute read

US NIH Initiates Trial to Assess Mix-Match of COVID-19 Vaccine Booster Shots: CNBC

By Vandana Singh

Today, 11:27 AM

The National Institutes of Health (NIH) has started an early-stage clinical trial to assess what happens when a…

BNTX

2 minute read

Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102

By Vandana Singh

Today, 11:27 AM

Protalix BioTherapeutics Inc (NYSE:PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX–102) for the…

PLX

1 minute read

Lilly’s Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial

By Vandana Singh

Today, 11:27 AM

Eli Lilly And Co (NYSE:LLY) has reported posthoc analyses data from the Phase 3 RA-BEAM study that showed Olumiant 4mg (baricitinib)…

ABBV

1 minute read

Almost Half of Crohn’s Disease Patients Achieved Endoscopic Response After One Year of Maintenance Treatment with AbbVie’s Risankizumab

By Vandana Singh

Today, 11:27 AM

AbbVie Inc (NYSE: ABBV) has announced positive top-line results from the Phase 3 maintenance study, FORTIFY, showing Skyrizi (risankizumab) achieved the co-primary endpoints of endoscopic response and clinical remission at one year in Crohn's disease.

ABBV